WOCKHARDT
|
The Current P/S Ratio of WOCKHARDT is 7.04.
Share Price | ₹1,286.2 | Mar 05,2025 |
Market Cap | ₹20,899.9 Cr | |
Sales-TTM | ₹2,969.0 Cr | TTM-Consolidated Results |
Price/Sales | 7.04x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of WOCKHARDT
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹20,899.9 Cr] as on Mar 05,2025
(/) Sales [ ₹2,969.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 7.04x ]
Thus, for WOCKHARDT , the investors are currently willing to pay '7.04 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WOCKHARDT !
The chart below summarizes the trend in P/S Ratio of WOCKHARDT over the last five years.
Historical PS (Price/Sales) ratio chart of WOCKHARDT
PS Ratio Performance Analysis for WOCKHARDT
- WOCKHARDT 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.52x.
- WOCKHARDT 's operated at median p/e ratio of 1.18x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WOCKHARDT 's p/e ratio peaked in Mar2024 at 3.21x.
- WOCKHARDT 's p/e ratio hit its five-year low in Mar2020 of 0.67x.
How does WOCKHARDT 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
WOCKHARDT | 2,969.0 | 7.04 | 20,899.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 51,602.5 | 7.36 | 379,563.0 |
DIVIS LABORATORIES LTD | 9,078.0 | 16.13 | 146,386.0 |
CIPLA LTD | 26,981.2 | 4.25 | 114,556.0 |
TORRENT PHARMACEUTICALS LTD | 11,302.0 | 8.93 | 100,914.0 |
DR REDDYS LABORATORIES LTD | 31,229.3 | 3.01 | 94,004.3 |
MANKIND PHARMA LTD | 11,641.0 | 8.11 | 94,416.5 |
ZYDUS LIFESCIENCES LTD | 22,247.4 | 4.01 | 89,308.3 |
LUPIN LTD | 22,001.6 | 4.17 | 91,748.8 |
AUROBINDO PHARMA LTD | 30,921.8 | 2.05 | 63,441.0 |
ABBOTT INDIA LTD | 6,243.2 | 10.68 | 66,689.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WOCKHARDT 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.05x |
Max industry PS | 16.13x |
Median industry PS | 7.04x |
Average industry PS | 6.88x |
You may also like the below Video Courses